CNS Pharmaceuticals, Inc. - Common Stock (NQ:CNSP)
6.010
+0.190
(+3.26%)
Streaming Delayed Price
Updated: 3:35 PM EST, Jan 12, 2026
Add to My Watchlist
All News about CNS Pharmaceuticals, Inc. - Common Stock
Preclinical Study Suggests Combo Therapy Could Treat Glioblastoma
January 07, 2026
Experts’ Views on Screen Time and Lifestyle on Pediatric Brain Tumors
December 29, 2025
CNS Pharmaceuticals Announces CEO Transition
December 17, 2025
Optimal Treatment Timing Could Boost Cancer Therapy Efficacy
December 10, 2025
Nasal Drops Hold Promise in Fighting Deadly Brain Cancer
December 05, 2025
Common Drug for Blood Pressure Could Slow Glioblastoma
November 25, 2025
Wegovy, Ozempic Could Reduce Deaths Resulting from Colon Cancer
November 14, 2025
12 Health Care Stocks Moving In Monday's After-Market Session ↗
November 10, 2025
New Implants Defy Necessity of Brain Surgery Against Cancer
November 10, 2025
What Patients Need to Know About the Remission Rate of Glioblastomas
October 28, 2025
Scientists Uncover Possible Driver of ‘Chemo Brain’
October 27, 2025
Virtual Brain Tumors Could Transform How Cancer is Treated
October 17, 2025
New AI Tool Boosts Precision Medicine in Treating CNS Cancers
October 13, 2025
Scientists Stunned Upon Discovering Glioblastoma Erodes Skull Tissue
October 09, 2025
Scorpion Venom Shows Promise in Brain Tumor Treatment
September 30, 2025
Rogue Rings of DNA Expose Brain Tumor Secrets
September 22, 2025
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
September 16, 2025
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
September 16, 2025
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.